Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009846 |
---|---|
Receipt number | R000010758 |
Scientific Title | Multicenter study on the Pharmacokinetics and pharmacogenetics of crizotinib in patients with ALK fusion gene positive NSCLC |
Date of disclosure of the study information | 2013/01/31 |
Last modified on | 2020/01/04 18:08:32 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/23 06:03:07 | ||
2 | Update | 2013/05/08 10:17:51 | Recruitment status Date of protocol fixation |
|
3 | Update | 2015/01/23 09:49:45 | Email |
|
4 | Update | 2015/01/23 09:50:37 | Recruitment status |
|
5 | Update | 2015/01/23 09:52:02 | Recruitment status |
|
6 | Update | 2017/06/04 13:29:30 | Name of primary person or sponsor Organization Category of Funding Organization |
|
7 | Update | 2017/06/04 13:29:52 | Recruitment status Publication of results |
|
8 | Update | 2020/01/04 17:51:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
9 | Update | 2020/01/04 17:58:02 | URL related to results and publications Number of participants that the trial has enrolled |
|
10 | Update | 2020/01/04 17:59:42 | Date of IRB Last follow-up date |
|
11 | Update | 2020/01/04 18:07:09 | URL releasing protocol Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
12 | Update | 2020/01/04 18:08:32 | Baseline Characteristics Adverse events |